The global market for Fluoxetine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Fluoxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used for the treatment of major depressive disorder, obsessive–compulsive disorder (OCD), bulimia nervosa, panic disorder and premenstrual dysphoric disorder. It may decrease the risk of suicide in those over the age of 65.

North American market for Fluoxetine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Fluoxetine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Fluoxetine include Teva, Sun Pharmaceutical, Sandoz, Mylan, Wockhardt, Dr.Reddy's Laboratories, Pharmaceutical Associates Inc., Lannett Company, Aurobindo Pharma, Alembic Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fluoxetine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluoxetine.

The Fluoxetine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fluoxetine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Fluoxetine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Fluoxetine Market Report

Report Metric	Details
Report Name	Fluoxetine Market
Segment by Type	Tablets Capsules Oral Solution
Segment by Application	Depression Obsessive–Compulsive Disorder Panic Disorder Bulimia Nervosa Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Teva, Sun Pharmaceutical, Sandoz, Mylan, Wockhardt, Dr.Reddy's Laboratories, Pharmaceutical Associates Inc., Lannett Company, Aurobindo Pharma, Alembic Pharmaceuticals, Alvogen, Torrent Pharmaceuticals, Suzhou YUSHI Pharmaceutical, Changzhou Siyao Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fluoxetine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fluoxetine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Fluoxetine Market report?

Ans: The main players in the Fluoxetine Market are Teva, Sun Pharmaceutical, Sandoz, Mylan, Wockhardt, Dr.Reddy's Laboratories, Pharmaceutical Associates Inc., Lannett Company, Aurobindo Pharma, Alembic Pharmaceuticals, Alvogen, Torrent Pharmaceuticals, Suzhou YUSHI Pharmaceutical, Changzhou Siyao Pharmaceutical

What are the Application segmentation covered in the Fluoxetine Market report?

Ans: The Applications covered in the Fluoxetine Market report are Depression, Obsessive–Compulsive Disorder, Panic Disorder, Bulimia Nervosa, Others

What are the Type segmentation covered in the Fluoxetine Market report?

Ans: The Types covered in the Fluoxetine Market report are Tablets, Capsules, Oral Solution

1 Fluoxetine Market Overview

1.1 Product Definition

1.2 Fluoxetine by Type

1.2.1 Global Fluoxetine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Tablets

1.2.3 Capsules

1.2.4 Oral Solution

1.3 Fluoxetine by Application

1.3.1 Global Fluoxetine Market Value by Application (2024 VS 2031)

1.3.2 Depression

1.3.3 Obsessive–Compulsive Disorder

1.3.4 Panic Disorder

1.3.5 Bulimia Nervosa

1.3.6 Others

1.4 Global Fluoxetine Market Size Estimates and Forecasts

1.4.1 Global Fluoxetine Revenue 2020-2031

1.4.2 Global Fluoxetine Sales 2020-2031

1.4.3 Global Fluoxetine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Fluoxetine Market Competition by Manufacturers

2.1 Global Fluoxetine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Fluoxetine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Fluoxetine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Fluoxetine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Fluoxetine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Fluoxetine, Product Type & Application

2.7 Global Key Manufacturers of Fluoxetine, Date of Enter into This Industry

2.8 Global Fluoxetine Market Competitive Situation and Trends

2.8.1 Global Fluoxetine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Fluoxetine Players Market Share by Revenue

2.8.3 Global Fluoxetine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Fluoxetine Market Scenario by Region

3.1 Global Fluoxetine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Fluoxetine Sales by Region: 2020-2031

3.2.1 Global Fluoxetine Sales by Region: 2020-2025

3.2.2 Global Fluoxetine Sales by Region: 2026-2031

3.3 Global Fluoxetine Revenue by Region: 2020-2031

3.3.1 Global Fluoxetine Revenue by Region: 2020-2025

3.3.2 Global Fluoxetine Revenue by Region: 2026-2031

3.4 North America Fluoxetine Market Facts & Figures by Country

3.4.1 North America Fluoxetine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Fluoxetine Sales by Country (2020-2031)

3.4.3 North America Fluoxetine Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Fluoxetine Market Facts & Figures by Country

3.5.1 Europe Fluoxetine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Fluoxetine Sales by Country (2020-2031)

3.5.3 Europe Fluoxetine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Fluoxetine Market Facts & Figures by Region

3.6.1 Asia Pacific Fluoxetine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Fluoxetine Sales by Region (2020-2031)

3.6.3 Asia Pacific Fluoxetine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Fluoxetine Market Facts & Figures by Country

3.7.1 Latin America Fluoxetine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Fluoxetine Sales by Country (2020-2031)

3.7.3 Latin America Fluoxetine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Fluoxetine Market Facts & Figures by Country

3.8.1 Middle East and Africa Fluoxetine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Fluoxetine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Fluoxetine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Fluoxetine Sales by Type (2020-2031)

4.1.1 Global Fluoxetine Sales by Type (2020-2025)

4.1.2 Global Fluoxetine Sales by Type (2026-2031)

4.1.3 Global Fluoxetine Sales Market Share by Type (2020-2031)

4.2 Global Fluoxetine Revenue by Type (2020-2031)

4.2.1 Global Fluoxetine Revenue by Type (2020-2025)

4.2.2 Global Fluoxetine Revenue by Type (2026-2031)

4.2.3 Global Fluoxetine Revenue Market Share by Type (2020-2031)

4.3 Global Fluoxetine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Fluoxetine Sales by Application (2020-2031)

5.1.1 Global Fluoxetine Sales by Application (2020-2025)

5.1.2 Global Fluoxetine Sales by Application (2026-2031)

5.1.3 Global Fluoxetine Sales Market Share by Application (2020-2031)

5.2 Global Fluoxetine Revenue by Application (2020-2031)

5.2.1 Global Fluoxetine Revenue by Application (2020-2025)

5.2.2 Global Fluoxetine Revenue by Application (2026-2031)

5.2.3 Global Fluoxetine Revenue Market Share by Application (2020-2031)

5.3 Global Fluoxetine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Teva

6.1.1 Teva Company Information

6.1.2 Teva Description and Business Overview

6.1.3 Teva Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Teva Fluoxetine Product Portfolio

6.1.5 Teva Recent Developments/Updates

6.2 Sun Pharmaceutical

6.2.1 Sun Pharmaceutical Company Information

6.2.2 Sun Pharmaceutical Description and Business Overview

6.2.3 Sun Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Sun Pharmaceutical Fluoxetine Product Portfolio

6.2.5 Sun Pharmaceutical Recent Developments/Updates

6.3 Sandoz

6.3.1 Sandoz Company Information

6.3.2 Sandoz Description and Business Overview

6.3.3 Sandoz Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Sandoz Fluoxetine Product Portfolio

6.3.5 Sandoz Recent Developments/Updates

6.4 Mylan

6.4.1 Mylan Company Information

6.4.2 Mylan Description and Business Overview

6.4.3 Mylan Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Mylan Fluoxetine Product Portfolio

6.4.5 Mylan Recent Developments/Updates

6.5 Wockhardt

6.5.1 Wockhardt Company Information

6.5.2 Wockhardt Description and Business Overview

6.5.3 Wockhardt Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Wockhardt Fluoxetine Product Portfolio

6.5.5 Wockhardt Recent Developments/Updates

6.6 Dr.Reddy's Laboratories

6.6.1 Dr.Reddy's Laboratories Company Information

6.6.2 Dr.Reddy's Laboratories Description and Business Overview

6.6.3 Dr.Reddy's Laboratories Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Dr.Reddy's Laboratories Fluoxetine Product Portfolio

6.6.5 Dr.Reddy's Laboratories Recent Developments/Updates

6.7 Pharmaceutical Associates Inc.

6.7.1 Pharmaceutical Associates Inc. Company Information

6.7.2 Pharmaceutical Associates Inc. Description and Business Overview

6.7.3 Pharmaceutical Associates Inc. Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Pharmaceutical Associates Inc. Fluoxetine Product Portfolio

6.7.5 Pharmaceutical Associates Inc. Recent Developments/Updates

6.8 Lannett Company

6.8.1 Lannett Company Company Information

6.8.2 Lannett Company Description and Business Overview

6.8.3 Lannett Company Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Lannett Company Fluoxetine Product Portfolio

6.8.5 Lannett Company Recent Developments/Updates

6.9 Aurobindo Pharma

6.9.1 Aurobindo Pharma Company Information

6.9.2 Aurobindo Pharma Description and Business Overview

6.9.3 Aurobindo Pharma Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Aurobindo Pharma Fluoxetine Product Portfolio

6.9.5 Aurobindo Pharma Recent Developments/Updates

6.10 Alembic Pharmaceuticals

6.10.1 Alembic Pharmaceuticals Company Information

6.10.2 Alembic Pharmaceuticals Description and Business Overview

6.10.3 Alembic Pharmaceuticals Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Alembic Pharmaceuticals Fluoxetine Product Portfolio

6.10.5 Alembic Pharmaceuticals Recent Developments/Updates

6.11 Alvogen

6.11.1 Alvogen Company Information

6.11.2 Alvogen Description and Business Overview

6.11.3 Alvogen Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Alvogen Fluoxetine Product Portfolio

6.11.5 Alvogen Recent Developments/Updates

6.12 Torrent Pharmaceuticals

6.12.1 Torrent Pharmaceuticals Company Information

6.12.2 Torrent Pharmaceuticals Description and Business Overview

6.12.3 Torrent Pharmaceuticals Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Torrent Pharmaceuticals Fluoxetine Product Portfolio

6.12.5 Torrent Pharmaceuticals Recent Developments/Updates

6.13 Suzhou YUSHI Pharmaceutical

6.13.1 Suzhou YUSHI Pharmaceutical Company Information

6.13.2 Suzhou YUSHI Pharmaceutical Description and Business Overview

6.13.3 Suzhou YUSHI Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Suzhou YUSHI Pharmaceutical Fluoxetine Product Portfolio

6.13.5 Suzhou YUSHI Pharmaceutical Recent Developments/Updates

6.14 Changzhou Siyao Pharmaceutical

6.14.1 Changzhou Siyao Pharmaceutical Company Information

6.14.2 Changzhou Siyao Pharmaceutical Description and Business Overview

6.14.3 Changzhou Siyao Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Changzhou Siyao Pharmaceutical Fluoxetine Product Portfolio

6.14.5 Changzhou Siyao Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Fluoxetine Industry Chain Analysis

7.2 Fluoxetine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Fluoxetine Production Mode & Process Analysis

7.4 Fluoxetine Sales and Marketing

7.4.1 Fluoxetine Sales Channels

7.4.2 Fluoxetine Distributors

7.5 Fluoxetine Customer Analysis

8 Fluoxetine Market Dynamics

8.1 Fluoxetine Industry Trends

8.2 Fluoxetine Market Drivers

8.3 Fluoxetine Market Challenges

8.4 Fluoxetine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Dr. Reddy’s Laboratories

Pharmaceutical Associates Inc.

Lannett Company

Aurobindo Pharma

Alembic Pharmaceuticals

Alvogen

Torrent Pharmaceuticals

Suzhou YUSHI Pharmaceutical

Changzhou Siyao Pharmaceutical

List of Tables

Table 1. Global Fluoxetine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Fluoxetine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Fluoxetine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Fluoxetine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Fluoxetine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Fluoxetine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Fluoxetine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Fluoxetine Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Fluoxetine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Fluoxetine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Fluoxetine, Product Type & Application

Table 12. Global Key Manufacturers of Fluoxetine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Fluoxetine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluoxetine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Fluoxetine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Fluoxetine Sales by Region (2020-2025) & (K Units)

Table 18. Global Fluoxetine Sales Market Share by Region (2020-2025)

Table 19. Global Fluoxetine Sales by Region (2026-2031) & (K Units)

Table 20. Global Fluoxetine Sales Market Share by Region (2026-2031)

Table 21. Global Fluoxetine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Fluoxetine Revenue Market Share by Region (2020-2025)

Table 23. Global Fluoxetine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Fluoxetine Revenue Market Share by Region (2026-2031)

Table 25. North America Fluoxetine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Fluoxetine Sales by Country (2020-2025) & (K Units)

Table 27. North America Fluoxetine Sales by Country (2026-2031) & (K Units)

Table 28. North America Fluoxetine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Fluoxetine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Fluoxetine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Fluoxetine Sales by Country (2020-2025) & (K Units)

Table 32. Europe Fluoxetine Sales by Country (2026-2031) & (K Units)

Table 33. Europe Fluoxetine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Fluoxetine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Fluoxetine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Fluoxetine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Fluoxetine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Fluoxetine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Fluoxetine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Fluoxetine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Fluoxetine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Fluoxetine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Fluoxetine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Fluoxetine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Fluoxetine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Fluoxetine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Fluoxetine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Fluoxetine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Fluoxetine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Fluoxetine Sales (K Units) by Type (2020-2025)

Table 51. Global Fluoxetine Sales (K Units) by Type (2026-2031)

Table 52. Global Fluoxetine Sales Market Share by Type (2020-2025)

Table 53. Global Fluoxetine Sales Market Share by Type (2026-2031)

Table 54. Global Fluoxetine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Fluoxetine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Fluoxetine Revenue Market Share by Type (2020-2025)

Table 57. Global Fluoxetine Revenue Market Share by Type (2026-2031)

Table 58. Global Fluoxetine Price (USD/Unit) by Type (2020-2025)

Table 59. Global Fluoxetine Price (USD/Unit) by Type (2026-2031)

Table 60. Global Fluoxetine Sales (K Units) by Application (2020-2025)

Table 61. Global Fluoxetine Sales (K Units) by Application (2026-2031)

Table 62. Global Fluoxetine Sales Market Share by Application (2020-2025)

Table 63. Global Fluoxetine Sales Market Share by Application (2026-2031)

Table 64. Global Fluoxetine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Fluoxetine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Fluoxetine Revenue Market Share by Application (2020-2025)

Table 67. Global Fluoxetine Revenue Market Share by Application (2026-2031)

Table 68. Global Fluoxetine Price (USD/Unit) by Application (2020-2025)

Table 69. Global Fluoxetine Price (USD/Unit) by Application (2026-2031)

Table 70. Teva Company Information

Table 71. Teva Description and Business Overview

Table 72. Teva Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Teva Fluoxetine Product

Table 74. Teva Recent Developments/Updates

Table 75. Sun Pharmaceutical Company Information

Table 76. Sun Pharmaceutical Description and Business Overview

Table 77. Sun Pharmaceutical Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Sun Pharmaceutical Fluoxetine Product

Table 79. Sun Pharmaceutical Recent Developments/Updates

Table 80. Sandoz Company Information

Table 81. Sandoz Description and Business Overview

Table 82. Sandoz Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Sandoz Fluoxetine Product

Table 84. Sandoz Recent Developments/Updates

Table 85. Mylan Company Information

Table 86. Mylan Description and Business Overview

Table 87. Mylan Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Mylan Fluoxetine Product

Table 89. Mylan Recent Developments/Updates

Table 90. Wockhardt Company Information

Table 91. Wockhardt Description and Business Overview

Table 92. Wockhardt Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Wockhardt Fluoxetine Product

Table 94. Wockhardt Recent Developments/Updates

Table 95. Dr.Reddy's Laboratories Company Information

Table 96. Dr.Reddy's Laboratories Description and Business Overview

Table 97. Dr.Reddy's Laboratories Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Dr.Reddy's Laboratories Fluoxetine Product

Table 99. Dr.Reddy's Laboratories Recent Developments/Updates

Table 100. Pharmaceutical Associates Inc. Company Information

Table 101. Pharmaceutical Associates Inc. Description and Business Overview

Table 102. Pharmaceutical Associates Inc. Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Pharmaceutical Associates Inc. Fluoxetine Product

Table 104. Pharmaceutical Associates Inc. Recent Developments/Updates

Table 105. Lannett Company Company Information

Table 106. Lannett Company Description and Business Overview

Table 107. Lannett Company Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Lannett Company Fluoxetine Product

Table 109. Lannett Company Recent Developments/Updates

Table 110. Aurobindo Pharma Company Information

Table 111. Aurobindo Pharma Description and Business Overview

Table 112. Aurobindo Pharma Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Aurobindo Pharma Fluoxetine Product

Table 114. Aurobindo Pharma Recent Developments/Updates

Table 115. Alembic Pharmaceuticals Company Information

Table 116. Alembic Pharmaceuticals Description and Business Overview

Table 117. Alembic Pharmaceuticals Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Alembic Pharmaceuticals Fluoxetine Product

Table 119. Alembic Pharmaceuticals Recent Developments/Updates

Table 120. Alvogen Company Information

Table 121. Alvogen Description and Business Overview

Table 122. Alvogen Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Alvogen Fluoxetine Product

Table 124. Alvogen Recent Developments/Updates

Table 125. Torrent Pharmaceuticals Company Information

Table 126. Torrent Pharmaceuticals Description and Business Overview

Table 127. Torrent Pharmaceuticals Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Torrent Pharmaceuticals Fluoxetine Product

Table 129. Torrent Pharmaceuticals Recent Developments/Updates

Table 130. Suzhou YUSHI Pharmaceutical Company Information

Table 131. Suzhou YUSHI Pharmaceutical Description and Business Overview

Table 132. Suzhou YUSHI Pharmaceutical Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Suzhou YUSHI Pharmaceutical Fluoxetine Product

Table 134. Suzhou YUSHI Pharmaceutical Recent Developments/Updates

Table 135. Changzhou Siyao Pharmaceutical Company Information

Table 136. Changzhou Siyao Pharmaceutical Description and Business Overview

Table 137. Changzhou Siyao Pharmaceutical Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Changzhou Siyao Pharmaceutical Fluoxetine Product

Table 139. Changzhou Siyao Pharmaceutical Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Fluoxetine Distributors List

Table 143. Fluoxetine Customers List

Table 144. Fluoxetine Market Trends

Table 145. Fluoxetine Market Drivers

Table 146. Fluoxetine Market Challenges

Table 147. Fluoxetine Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Fluoxetine

Figure 2. Global Fluoxetine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Fluoxetine Market Share by Type: 2024 & 2031

Figure 4. Tablets Product Picture

Figure 5. Capsules Product Picture

Figure 6. Oral Solution Product Picture

Figure 7. Global Fluoxetine Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Fluoxetine Market Share by Application: 2024 & 2031

Figure 9. Depression

Figure 10. Obsessive–Compulsive Disorder

Figure 11. Panic Disorder

Figure 12. Bulimia Nervosa

Figure 13. Others

Figure 14. Global Fluoxetine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Fluoxetine Market Size (2020-2031) & (US$ Million)

Figure 16. Global Fluoxetine Sales (2020-2031) & (K Units)

Figure 17. Global Fluoxetine Average Price (USD/Unit) & (2020-2031)

Figure 18. Fluoxetine Report Years Considered

Figure 19. Fluoxetine Sales Share by Manufacturers in 2024

Figure 20. Global Fluoxetine Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Fluoxetine Players: Market Share by Revenue in Fluoxetine in 2024

Figure 22. Fluoxetine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Fluoxetine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Fluoxetine Sales Market Share by Country (2020-2031)

Figure 25. North America Fluoxetine Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Fluoxetine Sales Market Share by Country (2020-2031)

Figure 29. Europe Fluoxetine Revenue Market Share by Country (2020-2031)

Figure 30. Germany Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Fluoxetine Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Fluoxetine Revenue Market Share by Region (2020-2031)

Figure 37. China Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Fluoxetine Sales Market Share by Country (2020-2031)

Figure 48. Latin America Fluoxetine Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Fluoxetine Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Fluoxetine Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. UAE Fluoxetine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Fluoxetine by Type (2020-2031)

Figure 58. Global Revenue Market Share of Fluoxetine by Type (2020-2031)

Figure 59. Global Fluoxetine Price (USD/Unit) by Type (2020-2031)

Figure 60. Global Sales Market Share of Fluoxetine by Application (2020-2031)

Figure 61. Global Revenue Market Share of Fluoxetine by Application (2020-2031)

Figure 62. Global Fluoxetine Price (USD/Unit) by Application (2020-2031)

Figure 63. Fluoxetine Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions